- €17.26m
- €22.86m
- €41.71m
- 54
- 60
- 36
- 46
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.3 | 25.8 | 31.6 | 47.3 | 41.7 |
Cost of Revenue | |||||
Gross Profit | 29.1 | 25 | 28.5 | 34 | 35.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 29.9 | 28.5 | 30.4 | 44.2 | 40.7 |
Operating Profit | 2.44 | -2.69 | 1.14 | 3.09 | 1.03 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2.37 | -3.03 | 1.11 | 2.67 | 0.702 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2 | -2.51 | 0.091 | 1.83 | -0.135 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.93 | -2.19 | -0.113 | 1.98 | -0.213 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.93 | -2.19 | -0.113 | 1.98 | -0.213 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.339 | -0.367 | -0.014 | 0.392 | -0.037 |
Dividends per Share |